ST PHARM is a technology-driven gene therapy CDMO (Contract Development and Manufacturing Organization) specializing in oligonucleotide to xRNA. It provides reliable and timely custom manufacturing services for APIs (Active Pharmaceutical Ingredients) with a focus on stringent quality systems and close client communication. It is a family company of the Dong-A Socio Group.
Focus Areas
Notable Investments
